Pharmacists in Bloomington, Minnesota


93 Pharmacists found in Bloomington
female pharmacist

Sonya Pickett, PHARMD


Pharmacist
7940 Penn Ave S, Bloomington, MN 55431
952-252-1154     952-252-1157

female pharmacist

Stacey Swier, PHARM D


Pharmacist
7601 Bristol Village Dr, Bloomington, MN 55438
605-310-0773    

female pharmacist

Ms. Stefanie L Nyman, PHARMD, MPA


Pharmacist
3916 W Old Shakopee Rd, Bloomington, MN 55437
952-252-1062    



female pharmacist

Stephanie Melby, PHARMD


Pharmacist
8421 Lyndale Ave S, Bloomington, MN 55420
952-881-4299    

male pharmacist

Theodore Glen Ranheim, RPH


Pharmacist
7131 Oak Pointe Curv, Bloomington, MN 55438
952-941-3568    

female pharmacist

Theresa Zotaley


Pharmacist
2555 W 79th St, Bloomington, MN 55431
952-933-5333     952-933-5333

female pharmacist

Thu-thao Phan-ly, PHARMD


Pharmacist
2555 W 79th St, Bloomington, MN 55431
952-888-4677    

female pharmacist

Dr. Tien Vuong, PHARMD


Pharmacist
200 American Blvd W, Bloomington, MN 55420
952-888-6079    

male pharmacist

Timothy Casey


Pharmacist
7845 Portland Ave S, Bloomington, MN 55420
952-881-1253     952-881-2656

male pharmacist

Tyler Rother, PHARMD


Pharmacist
200 American Blvd W, Bloomington, MN 55420
952-888-6079    

male pharmacist

Wesley Pederson


Pharmacist
9800 Lyndale Ave S, Bloomington, MN 55420
952-884-8246    

female pharmacist

Whitney Toppen


Pharmacist
10520 France Ave S, Bloomington, MN 55431
952-888-4310    

male pharmacist

Dr. Youssef Roman, PHARM.D., PH.D.


Pharmacist
8170 33rd Ave S, Bloomington, MN 55425
952-883-6000    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.